Pediatric pituitary adenomas (PPAs) are rare neoplasms with a propensity for unusual presentations and an aggressive clinical course. Here, the authors describe 6 highly atypical PPAs to highlight this tendency and discuss unexpected management challenges.
A 14-year-old girl presented with acute hemiparesis and aphasia. MRI revealed a pituitary macroadenoma causing internal carotid artery invasion/obliteration without acute apoplexy, which was treated via emergent transsphenoidal resection (TSR). Another 14-year-old girl developed precocious galactorrhea due to macroprolactinoma, which was medically managed. Several years later, she re-presented with acute, severe, bitemporal hemianopia during her third trimester of pregnancy, requiring emergent induction of labor followed by TSR. A 13-year-old boy was incidentally diagnosed with a prolactinoma after routine orthodontic radiographs captured a subtly abnormal sella. An 18-year-old male self-diagnosed pituitary gigantism through a school report on pituitary disease. A 17-year-old boy was diagnosed with Cushing disease by his basketball coach, a former endocrinologist. A 12-year-old girl with growth arrest and weight gain was diagnosed with Cushing disease, which was initially treated via TSR but subsequently recurred and ultimately required 12 operations, 5 radiation treatments involving 3 modalities, bilateral adrenalectomy, and chemotherapy. Despite these efforts, she ultimately died from pituitary carcinoma.
Correspondence Fredric B. Meyer: Mayo Clinic, Rochester, MN. firstname.lastname@example.org.INCLUDE WHEN CITING Published online October 11, 2019; DOI: 10.3171/2019.7.PEDS1950.Disclosures The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.
AbeT, TaraLA, LüdeckeDK: Growth hormone-secreting pituitary adenomas in childhood and adolescence: features and results of transnasal surgery. 45:1–10, 199910.1227/00006123-199907000-0000110414559)| false
ChenJCAmarAPChoiSSingerPCouldwellWTWeissMH: Transsphenoidal microsurgical treatment of Cushing disease: postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test. J Neurosurg98:967–9732003
ChivukulaS, KoutourousiouM, SnydermanCH, Fernandez-MirandaJC, GardnerPA, Tyler-KabaraEC: Endoscopic endonasal skull base surgery in the pediatric population. 11:227–241, 201310.3171/2012.10.PEDS1216023240846)| false
EspositoFDusickJRCohanPMoftakharPMcArthurDWangC: Clinical review: Early morning cortisol levels as a predictor of remission after transsphenoidal surgery for Cushing’s disease. J Clin Endocrinol Metab91:7–132006
EspositoF, DusickJR, CohanP, MoftakharP, McArthurD, WangC, : Clinical review: Early morning cortisol levels as a predictor of remission after transsphenoidal surgery for Cushing’s disease. 91:7–13, 200610.1210/jc.2005-120416234305)| false
JoshiSM, HewittRJ, StorrHL, RezajooiK, EllamushiH, GrossmanAB, : Cushing’s disease in children and adolescents: 20 years of experience in a single neurosurgical center. 57:281–285, 200510.1227/01.NEU.0000166580.94215.53)| false
KellyDF: Transsphenoidal surgery for Cushing’s disease: a review of success rates, remission predictors, management of failed surgery, and Nelson’s Syndrome. 23(3):E5, 20071796102610.3171/foc.2007.23.3.7)| false
LeinungMC, KaneLA, ScheithauerBW, CarpenterPC, LawsERJr, ZimmermanD: Long term follow-up of transsphenoidal surgery for the treatment of Cushing’s disease in childhood. 80:2475–2479, 19957629245)| false
MelmedS, CasanuevaFF, HoffmanAR, KleinbergDL, MontoriVM, SchlechteJA, : Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. 96:273–288, 201110.1210/jc.2010-169221296991)| false
NakaneT, KuwayamaA, WatanabeM, TakahashiT, KatoT, IchiharaK, : Long term results of transsphenoidal adenomectomy in patients with Cushing’s disease. 21:218–222, 198710.1227/00006123-198708000-000152821447)| false
PerryA, GraffeoCS, MarcellinoC, PollockBE, WetjenNM, MeyerFB: Pediatric pituitary adenoma: case series, review of the literature, and a skull base treatment paradigm. 79:91–114, 201810.1055/s-0038-1625984)| false
RollinGA, FerreiraNP, JungesM, GrossJL, CzepielewskiMA: Dynamics of serum cortisol levels after transsphenoidal surgery in a cohort of patients with Cushing’s disease. 89:1131–1139, 200410.1210/jc.2003-031170)| false
RostomyanL, DalyAF, PetrossiansP, NachevE, LilaAR, LecoqAL, : Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients. 22:745–757, 20152618712810.1530/ERC-15-0320)| false
ZimmermanDYoungWFJrEbersoldMJScheithauerBWKovacsKHorvathE: Congenital gigantism due to growth hormone-releasing hormone excess and pituitary hyperplasia with adenomatous transformation. J Clin Endocrinol Metab76:216–2221993